KOPN
Kopin CorpCompany with tickers: KOPN
CIK
771266
CUSIP
500600101
Shares Outstanding
185,301,283
Website
https://www.kopin.com
Investor Relations
https://www.kopin.com/investors/
13F Activity (30d)
5 filings
4 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $15,000,000 | USD | 2026-04-27 | 10-Q | 2026-05-12 |
| Operating Income | — | ||||
| Net Income | — | ||||
| EPS (Basic) | — | ||||
| EPS (Diluted) | — |
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
By Geography (USD)
| Component | 2020-12-26 | 2021-12-25 | 2022-12-31 | 2023-12-30 | 2024-12-28 | 2025-12-27 |
|---|---|---|---|---|---|---|
| Americas | $33,132,000 | $32,461,000 | $38,608,000 | $35,097,000 | $47,564,000 | $37,209,000 |
| United States | $33,031,000 | $32,461,000 | $38,604,000 | $35,092,000 | $47,559,000 | $37,147,000 |
| Asia Pacific | $5,798,000 | $11,852,000 | $7,791,000 | $3,766,000 | $1,989,000 | $1,154,000 |
| Europe | $1,198,000 | $1,353,000 | $1,002,000 | $1,531,000 | $782,000 | $961,000 |
| Other Americas | $101,000 | — | $4,000 | $5,000 | $5,000 | $62,000 |
By Product & Service (USD)
| Component | 2020-12-26 | 2021-12-25 | 2022-12-31 | 2023-12-30 | 2024-12-28 | 2025-12-27 |
|---|---|---|---|---|---|---|
| ASC Six Zero Six Revenues | — | — | — | — | $50,335,000 | $38,067,000 |
| Net Product Revenue | — | — | — | — | $43,576,000 | $33,067,000 |
| Net Product Revenues | $28,517,874 | $29,882,271 | $32,420,397 | $25,937,170 | $43,576,723 | $33,066,843 |
| Defense | $20,231,000 | $18,180,000 | $24,780,000 | $22,615,000 | $41,249,000 | $29,361,000 |
| Research And Development | $10,123,000 | $14,669,000 | $14,357,000 | $13,455,000 | $5,997,000 | $4,590,000 |
| Research And Development Revenues | $10,122,677 | $14,668,471 | $14,357,222 | $13,454,866 | $5,996,362 | $4,589,986 |
| Industrial | $6,882,000 | $9,710,000 | $6,136,000 | $2,736,000 | $2,200,000 | $3,025,000 |
| Non ASC Six Zero Six Revenues | — | — | — | — | — | $1,257,000 |
| Grant Income | — | — | — | — | — | $858,092 |
| Grant | — | — | — | — | — | $858,000 |
| Medical | — | — | — | — | $103,000 | $594,000 |
| License And Royalties | $1,487,000 | $1,115,000 | $624,000 | $1,002,000 | $762,000 | $410,000 |
| License And Other Revenues | $1,487,118 | $1,115,375 | $623,571 | $1,002,141 | $762,082 | $409,899 |
| Collaboration | — | — | — | — | — | $399,000 |
| Collaboration Arrangement Income | — | — | — | — | — | $398,911 |
| Other Product | — | — | $7,000 | $13,000 | $320,000 | $78,000 |
| Consumer | $852,000 | $1,871,000 | $1,497,000 | $573,000 | $24,000 | $9,000 |
| Other | $553,000 | $121,000 | $7,000 | $13,000 | — | — |